VALNEVA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.112 EUR | +2.24% |
|
+5.33% | -13.41% |
| 05-31 | Valneva's Chikungunya Vaccine Gains Support From EU Regulator Committee | MT |
| 05-31 | EU regulator recommends use of Valneva's chikungunya vaccine | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 54.64B | - | |||||
| 39.92B | ||||||
| 38.82B | ||||||
| 26.86B | ||||||
| 26.22B |
- Stock Market
- Equities
- VLA Stock
- AYJ Stock
- Charts Valneva
- Sector Chart
